Supha Arthurs is an Infectious Disease physician. OpenAlex indexes 7 publications with 795 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
222 N 7th St
Bismarck, ND 585014436
Telephone
701-323-5422Provider last certified this registry record 18 Dec 2019.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20253 payments
- GlaxoSmithKline, LLC.Program year20253 payments
- HARMONY BIOSCIENCES LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
92.5%Other antibacterials28.3%Methenamine Hippurate100%Part D≥35 patientsTetracycline-class Drug11.9%Doxycycline Hyclate67%Minocycline Hcl17%Doxycycline Monohydrate16%Part D<11 patients+ 14 more classes in this area
Sensory organs
2.9%Fluoroquinolone Antibacterial2.9%Ciprofloxacin Hcl100%Part D≥16 patientsDermatology
1.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor1.6%Acyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients
American Journal of Transplantation
2009 - The impact of invasive fungal diseases on survival after lung transplantation
Clinical Transplantation
2009 - Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation
Clinical Infectious Diseases
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”